1. Home
  2. MYND vs IOBT Comparison

MYND vs IOBT Comparison

Compare MYND & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mynd.ai Inc.

MYND

Mynd.ai Inc.

HOLD

Current Price

$0.34

Market Cap

14.6M

Sector

Real Estate

ML Signal

HOLD

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.04

Market Cap

12.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYND
IOBT
Founded
1998
2014
Country
United States
Denmark
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
12.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MYND
IOBT
Price
$0.34
$0.04
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.25
AVG Volume (30 Days)
6.7K
40.5M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.77
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.03
52 Week High
$1.15
$2.79

Technical Indicators

Market Signals
Indicator
MYND
IOBT
Relative Strength Index (RSI) 43.42 25.94
Support Level $0.29 N/A
Resistance Level $0.36 $0.22
Average True Range (ATR) 0.02 0.02
MACD 0.00 -0.01
Stochastic Oscillator 66.39 15.92

Price Performance

Historical Comparison
MYND
IOBT

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: